Bio-Gene Technology Limited (ASX:BGT)
Australia flag Australia · Delayed Price · Currency is AUD
0.0350
0.00 (0.00%)
Mar 9, 2026, 3:03 PM AEST

Bio-Gene Technology Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2020 - 2016
Market Capitalization
11410142326
Upgrade
Market Cap Growth
12.82%-56.80%-28.90%-40.05%-11.38%32.95%
Upgrade
Enterprise Value
1037101721
Upgrade
Last Close Price
0.040.020.050.080.130.17
Upgrade
PS Ratio
--538.5892.9951.93417.15
Upgrade
PB Ratio
9.152.623.544.313.696.15
Upgrade
P/TBV Ratio
10.482.923.814.663.866.64
Upgrade
EV/Sales Ratio
--362.4364.4738.88337.31
Upgrade
Net Debt / Equity Ratio
-0.93-0.70-0.79-0.93-1.01-0.93
Upgrade
Net Debt / EBITDA Ratio
0.430.440.900.952.171.64
Upgrade
Net Debt / FCF Ratio
0.410.450.800.913.172.15
Upgrade
Asset Turnover
--0.010.030.070.01
Upgrade
Quick Ratio
3.643.167.905.996.727.52
Upgrade
Current Ratio
4.313.868.496.246.947.87
Upgrade
Return on Equity (ROE)
-202.18%-116.99%-80.14%-65.24%-55.43%-46.76%
Upgrade
Return on Assets (ROA)
-94.90%-61.77%-44.61%-35.71%-30.14%-26.30%
Upgrade
Return on Capital Employed (ROCE)
-217.00%-160.00%-88.70%-97.60%-47.10%-55.20%
Upgrade
Earnings Yield
-23.61%-60.63%-24.42%-22.31%-12.59%-9.18%
Upgrade
FCF Yield
--59.65%-27.97%-23.61%-8.64%-7.00%
Upgrade
Buyback Yield / Dilution
-34.05%-13.68%-10.76%-9.41%-11.73%-14.96%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.